OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
21
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Publication Date
Release Date
2021
(5)
2025
(3)
2024
(3)
2023
(2)
2022
(2)
2020
(2)
2016
(2)
2019
(1)
2012
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Metabolic Imaging of Advanced Basal Cell Carcinoma Treated with Sonidegib: A Retrospective Case Series Study.
Not available
S-EPMC11396429
|
biostudies-literature
Cite
Long-Term Maintained Response to Selective Internal Radiation Therapy in an Oligometastatic Uveal Melanoma Patient Treated with Concomitant Anti-PD-1 Therapy.
Not available
S-EPMC8307638
|
biostudies-literature
Cite
Clinical Applications of TSPO PET for Glioma Imaging: Current Evidence and Future Perspective-A Systematic Review.
Not available
S-EPMC10217690
|
biostudies-literature
Cite
Detection Rate and Clinical Impact of PET/CT with 18F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study.
Not available
S-EPMC8773479
|
biostudies-literature
Cite
Transcriptomic Characterization of Cow, Donkey and Goat Milk Extracellular Vesicles Reveals Their Anti-Inflammatory and Immunomodulatory Potential.
Not available
S-EPMC8657891
|
biostudies-literature
Cite
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial.
Not available
S-EPMC8579271
|
biostudies-literature
Cite
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma.
Not available
S-EPMC11637738
|
biostudies-literature
Cite
Multiple sclerosis from onset to secondary progression: a 30-year Italian register study.
Not available
S-EPMC12573403
|
biostudies-literature
Cite
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II).
Not available
S-EPMC12058817
|
biostudies-literature
Cite
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.
Not available
S-EPMC12584038
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets